Erin Chung

6.4k total citations
17 papers, 283 citations indexed

About

Erin Chung is a scholar working on Infectious Diseases, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Erin Chung has authored 17 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Pharmacology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Erin Chung's work include Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Neonatal and Maternal Infections (3 papers). Erin Chung is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (5 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Neonatal and Maternal Infections (3 papers). Erin Chung collaborates with scholars based in Canada, United States and Australia. Erin Chung's co-authors include Linden T. Hu, Jonathan Sen, Tanja Petnicki‐Ocwieja, Winnie Seto, Adriana Marques, Peter J. Krause, Sam R. Telford, Heather E. Carolan, Kenneth R. Dardick and Siu-Ping Turk and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Infection and Immunity.

In The Last Decade

Erin Chung

17 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erin Chung Canada 8 150 137 51 42 41 17 283
Katharina L. Lohmann Canada 12 79 0.5× 52 0.4× 103 2.0× 47 1.1× 51 1.2× 41 408
Deyong Chu China 10 95 0.6× 183 1.3× 52 1.0× 36 0.9× 41 1.0× 24 339
S Kasuya Japan 12 42 0.3× 151 1.1× 40 0.8× 18 0.4× 12 0.3× 21 375
Tânia Zaverucha do Valle Brazil 12 132 0.9× 61 0.4× 61 1.2× 168 4.0× 60 1.5× 27 387
Qingqing Bian China 10 60 0.4× 130 0.9× 21 0.4× 7 0.2× 72 1.8× 21 290
Tamara Silva Rodrigues Brazil 8 65 0.4× 27 0.2× 54 1.1× 66 1.6× 67 1.6× 17 252
Policarpo A. Sales-Junior Brazil 9 45 0.3× 145 1.1× 113 2.2× 130 3.1× 57 1.4× 11 343
Emily Yang United States 7 70 0.5× 73 0.5× 86 1.7× 51 1.2× 97 2.4× 8 323
Kokouvi Kassegne China 12 83 0.6× 118 0.9× 54 1.1× 139 3.3× 85 2.1× 29 383
Ikram Omar Osman France 6 145 1.0× 41 0.3× 22 0.4× 13 0.3× 24 0.6× 11 195

Countries citing papers authored by Erin Chung

Since Specialization
Citations

This map shows the geographic impact of Erin Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Chung more than expected).

Fields of papers citing papers by Erin Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erin Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Chung. The network helps show where Erin Chung may publish in the future.

Co-authorship network of co-authors of Erin Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Erin Chung. A scholar is included among the top collaborators of Erin Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erin Chung. Erin Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chung, Erin, et al.. (2023). Utilizing therapeutic drug monitoring to optimize therapy with eculizumab and mycophenolate mofetil in a child with C3 glomerulonephritis. Pediatric Nephrology. 38(10). 3483–3487. 1 indexed citations
2.
Chung, Erin & Winnie Seto. (2023). Association between vancomycin therapeutic drug monitoring and clinical outcomes in treating neonatal sepsis. International Journal of Antimicrobial Agents. 62(4). 106958–106958. 5 indexed citations
3.
Chung, Erin & Winnie Seto. (2023). Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase‐negative staphylococcus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 43(12). 1262–1276. 6 indexed citations
4.
Hoban, Rebecca, et al.. (2022). Metabolic acidosis during continuous glucagon therapy for neonatal hypoglycemia. Paediatrics & Child Health. 28(1). 24–29. 1 indexed citations
5.
Chung, Erin, et al.. (2021). Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration. Kidney International Reports. 6(4). 1003–1014. 3 indexed citations
6.
Chung, Erin, Jonathan Sen, Priya Patel, & Winnie Seto. (2021). Population Pharmacokinetic Models of Vancomycin in Paediatric Patients: A Systematic Review. Clinical Pharmacokinetics. 60(8). 985–1001. 16 indexed citations
7.
Yeung, Telford, Erin Chung, Jennifer Chen, et al.. (2021). Therapeutic Drug Monitoring of Moxifloxacin to Guide Treatment of Mycoplasma hominis Meningitis in an Extremely Preterm Infant. The Journal of Pediatric Pharmacology and Therapeutics. 26(8). 857–862. 2 indexed citations
8.
Sen, Jonathan, Erin Chung, Christopher Neil, & Thomas H. Marwick. (2020). Antihypertensive therapies in moderate or severe aortic stenosis: a systematic review and meta-analysis. BMJ Open. 10(10). e036960–e036960. 4 indexed citations
9.
Sen, Jonathan, Erin Chung, & Darryl McGill. (2018). Tolvaptan for Heart Failure in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis. Heart Lung and Circulation. 27(8). 928–939. 20 indexed citations
10.
Chung, Erin, et al.. (2018). Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population. Journal of Neonatal-Perinatal Medicine. 12(1). 21–27. 6 indexed citations
11.
Chung, Erin, et al.. (2017). NICU Primer for Pharmacists. The Canadian Journal of Hospital Pharmacy. 70(3). 1 indexed citations
12.
Marques, Adriana, Sam R. Telford, Siu-Ping Turk, et al.. (2014). Xenodiagnosis to Detect Borrelia burgdorferi Infection: A First-in-Human Study. Clinical Infectious Diseases. 58(7). 937–945. 87 indexed citations
13.
Maruf, Abdullah Al, et al.. (2013). Modeling xenobiotic susceptibility to hepatotoxicity using an in vitro oxidative stress inflammation model. Canadian Journal of Physiology and Pharmacology. 91(3). 236–240. 11 indexed citations
14.
Chung, Erin, Elsa Petit, Janis Antonovics, Amy B. Pedersen, & Michael E. Hood. (2012). Variation in resistance to multiple pathogen species: anther smuts of Silene uniflora. Ecology and Evolution. 2(9). 2304–2314. 24 indexed citations
15.
Chung, Erin & Jonathan Sen. (2012). The ongoing pursuit of a prophylactic HSV vaccine. Reviews in Medical Virology. 22(5). 285–300. 9 indexed citations
16.
Petnicki‐Ocwieja, Tanja, Erin Chung, David Acosta, et al.. (2012). TRIF Mediates Toll-Like Receptor 2-Dependent Inflammatory Responses to Borrelia burgdorferi. Infection and Immunity. 81(2). 402–410. 50 indexed citations
17.
Petnicki‐Ocwieja, Tanja, et al.. (2011). Nod2 Suppresses Borrelia burgdorferi Mediated Murine Lyme Arthritis and Carditis through the Induction of Tolerance. PLoS ONE. 6(2). e17414–e17414. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026